FDG Whole-Body PET/MRI in Oncology: a Systematic Review

• Published in: Nuclear medicine and molecular imaging Vol. 51; no. 1; pp. 22 - 31
• Main Authors: Kwon, Hyun Woo, Becker, Ann-Katharina, Goo, Jin Mo, Cheon, Gi Jeong
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.03.2017; Springer Nature B.V; 대한핵의학회
• Subjects: Cardiology; Computed tomography; Diagnostic systems; Imaging; Imaging techniques; Magnetic resonance imaging; Medical imaging; Medicine; Medicine & Public Health; NMR; Nuclear magnetic resonance; Nuclear Medicine; Oncology; Orthopedics; Positron emission; Radiology; Review; Tomography; Tumors; 방사선과학; FDG; Oncology; PET/MRI; Positron emission tomography/magnetic resonance imaging
• ISSN: 1869-3474; 1869-3482
• DOI: 10.1007/s13139-016-0411-3

The recent advance in hybrid imaging techniques enables offering simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) in various clinical fields. 18 F-fluorodeoxyglucose (FDG) PET has been widely used for diagnosis and evaluation of oncologic patients. The growing evidence from research and clinical experiences demonstrated that PET/MRI with FDG can provide comparable or superior diagnostic performance more than conventional radiological imaging such as computed tomography (CT), MRI or PET/CT in various cancers. Combined analysis using structural information and functional/molecular information of tumors can draw additional diagnostic information based on PET/MRI. Further studies including determination of the diagnostic efficacy, optimizing the examination protocol, and analysis of the hybrid imaging results is necessary for extending the FDG PET/MRI application in clinical oncology.